Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128186) titled 'The Application of an AI-driven Multimodal Predictive Model for Cognitive Impairment in Patients With Type 2 Diabetes Mellitus' on Aug. 11.
Study Type: Observational [Patient Registry]
Primary Sponsor: Tongji Hospital
Condition:
Cognitive Dysfunction
Intervention:
Other: follow-up observation
Recruitment Status: Recruiting
Date of First Enrollment: April 22, 2025
Target Sample Size: 5000
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128186
Disclaimer: Curated by HT Syndication....